<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53236">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413138</url>
  </required_header>
  <id_info>
    <org_study_id>J14VR5</org_study_id>
    <nct_id>NCT02413138</nct_id>
  </id_info>
  <brief_title>Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)</brief_title>
  <official_title>A Randomized, Phase 2/3, Open-Label, Multi-center Study of the Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of A Long-acting Human Growth Hormone (Somavaratan, VRS-317) in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versartis Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versartis Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial will consist of three stages: 1) a 30 day Phase 2 PK and PD evaluation of
      somavaratan, 2) an optional Phase 2 Extension and 3) a 12 month Phase 3 safety and efficacy
      stage. Upon completion of the PK/PD stage, the PK/PD profiles for the GHD children in this
      study will be compared to the PK/PD profiles for the GHD children treated in the Western
      study Phase 1b/2a study (Protocol 12VR2) and identify the somavaratan dose to be used in the
      Phase 3 stage in Japan. The Phase 3 stage will continue dosing for 12 months to obtain
      safety and efficacy data on 48 subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial will consist of three stages: 1) a 30 day Phase 2 PK and PD evaluation of
      somavaratan, 2) an optional Phase 2 Extension and 3) a 12 month Phase 3 safety and efficacy
      stage. The study is a randomized, multi-center, open label study. The primary endpoint is
      height velocity at 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy (Annual Height velocity)</measure>
    <time_frame>12 months</time_frame>
    <description>Annual Height velocity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharmacodynamics (IGF-I responses to study drug administration)</measure>
    <time_frame>12 months</time_frame>
    <description>IGF-I responses to study drug administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacodynamics (IGFBP-3 responses to study drug administration)</measure>
    <time_frame>12 months</time_frame>
    <description>IGFBP-3 responses to study drug administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Number of subjects with adverse events )</measure>
    <time_frame>12 months</time_frame>
    <description>Number of subjects with adverse events (including repeat dose immunogenicity).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Concomitant medications)</measure>
    <time_frame>12 months</time_frame>
    <description>Concomitant medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Safety labs)</measure>
    <time_frame>12 months</time_frame>
    <description>Safety labs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Vital signs)</measure>
    <time_frame>12 months</time_frame>
    <description>Vital signs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Physical Exams)</measure>
    <time_frame>12 months</time_frame>
    <description>Physical Exams</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Secondary Efficacy (Change in height SDS)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in height SDS.</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Efficacy</measure>
    <time_frame>12 months</time_frame>
    <description>Change in body weight</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Efficacy</measure>
    <time_frame>12 months</time_frame>
    <description>Change in body mass index.</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Efficacy (Change in bone age)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in bone age.</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary Efficacy (Change in pubertal staging.)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in pubertal staging.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Pediatric Growth Hormone Deficiency</condition>
  <condition>Growth Disorders</condition>
  <arm_group>
    <arm_group_label>Phase 2: Somavaratan (VRS-317)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active treatment arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 3: Somavaratan (VRS-317)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Somavaratan long acting recombinant human growth hormone administered subcutaneously twice-monthly</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Somavaratan (VRS-317)</intervention_name>
    <description>Long acting recombinant human growth hormone</description>
    <arm_group_label>Phase 2: Somavaratan (VRS-317)</arm_group_label>
    <arm_group_label>Phase 3: Somavaratan (VRS-317)</arm_group_label>
    <other_name>Long acting recombinant human growth hormone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronological Age ≥ 3.0 years and ≤ 9.0 years (girls) or ≤ 10.0 years (boys)

          -  Pre-pubertal status

          -  Diagnosis of GHD as documented by two or more GH stimulation test results

          -  Height SD score ≤ -2.0 at screening

          -  Weight for Stature ≥ 10th percentile

          -  IGF-I SD score ≤ -1.0 at screening

          -  Delayed bone age

        Exclusion Criteria:

          -  Prior treatment with any growth promoting agent

          -  History of, or current, significant disease

          -  Chromosomal aneuploidy, significant gene mutations (other than those that cause GHD)
             or confirmed diagnosis of a named syndrome

          -  Birth weight and/or birth length less than 5th percentile for gestational age

          -  A diagnosis of Attention Deficit Hyperactivity Disorder

          -  Daily use of anti-inflammatory doses of glucocorticoid

          -  Prior history of leukemia, lymphoma, sarcoma or cancer

          -  Ocular findings suggestive of increased intracranial pressure and/or retinopathy at
             screening

          -  Significant spinal abnormalities including scoliosis, kyphosis and spina bifida
             variants

          -  Significant abnormality in screening laboratory studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomonobu Hasegawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keio University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Humphriss, MBA</last_name>
    <phone>650.963.8587</phone>
    <email>ehumphriss@versartis.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Schumacher, MBA</last_name>
    <phone>650.433.2621</phone>
    <email>mschumacher@versartis.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Akita University Hospital</name>
      <address>
        <city>Akita</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2612</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ehime University Hospital</name>
      <address>
        <city>Ehime</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fukuoka Children's Hospital</name>
      <address>
        <city>Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fukuoka University Hospital</name>
      <address>
        <city>Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>(650) 433-2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gunma University Hospital</name>
      <address>
        <city>Gunma</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hamamatsu University Hospital</name>
      <address>
        <city>Hamamatsu</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kure Medical Center</name>
      <address>
        <city>Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Hospital</name>
      <address>
        <city>Hokkaido</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Morioka Children's Hospital</name>
      <address>
        <city>Iwate</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>(650) 433-2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kanagawa Prefectural Hospital</name>
      <address>
        <city>Kanagawa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kanazawa Medical University Hospital</name>
      <address>
        <city>Kanazawa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kumamoto University Hospital</name>
      <address>
        <city>Kumamoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Miyazaki Hospital</name>
      <address>
        <city>Miyazaki</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>(650) 433-2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aichi Children's Health and Medical Center</name>
      <address>
        <city>Nagoya</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nagoya City University Hospital</name>
      <address>
        <city>Nagoya</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Niigata University Medical and Dental Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Oita University Hospital</name>
      <address>
        <city>Oita</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Okayama Saiseikai General Hospital</name>
      <address>
        <city>Okayama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Japan Community Health care Organization Osaka Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Osaka Medical Center and Reserach Institute for Maternal and Child Health</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Osaka Police Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>(650) 433-2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Osaka University Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Saitama Children's Medical Center</name>
      <address>
        <city>Saitama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shiga University of Medical Science Hospital</name>
      <address>
        <city>Shiga</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Keio University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National Center for Child Health and Development</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nihon University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Saitama Medical University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tanaka Growth Clinic</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Jikei University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tohoku University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tokyo Metropolitan Children's Medical Center</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Toranomon Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tottori University Hosptial</name>
      <address>
        <city>Tottori</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>650.433.2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Iwakuni Medical Center</name>
      <address>
        <city>Yamaguchi</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Hoshino, MD</last_name>
      <email>yhoshino@versartis.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Schumacher</last_name>
      <phone>(650) 433-2621</phone>
      <email>mschumacher@versartis.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 4, 2016</lastchanged_date>
  <firstreceived_date>March 23, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GHD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endocrine System Diseases</mesh_term>
    <mesh_term>Dwarfism, Pituitary</mesh_term>
    <mesh_term>Growth Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
